RecruitingPhase 4NCT03783182

Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy

Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy - a Randomized, Double-blind, Placebo-controlled Trial


Sponsor

Umeå University

Enrollment

100 participants

Start Date

Sep 10, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

Betamethasone is currently given routinely in conjunction with tonsillectomy surgery at the majority of Ear, Nose \& Throat clinics in Sweden. The scientific evidence regarding the effects of betamethasone in adults is limited when it comes to postoperative nausea (PONV), pain and postoperative bleeding.


Eligibility

Min Age: 12 Years

Inclusion Criteria1

  • Signed informed consent Age over 12 years Planned for elective bilateral tonsillectomy

Exclusion Criteria7

  • Insulin dependent diabetes mellitus
  • NSAID or corticosteroid intolerance
  • Pregnancy
  • Gastric ulcer
  • Immunodeficiency
  • Treatment for chronic pain
  • Psychiatric disorders

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBetamethason Sodium Phosphate

Glucocorticoid

DRUG10% glucose solution

Glucose solution that can be used for injection, but in this case it is used perorally (one ml)


Locations(1)

Sunderby sjukhus

Luleå, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03783182


Related Trials